News about "Active Pharmaceutical Ingredients "

Indoco Remedies Receives Seven Form 483 Observations Following US FDA Inspection

Indoco Remedies’ Plant 2 (Sterile) facility in Goa received seven Form 483 observations following a USFDA inspection conducted from August 27 to September 4, 2026.

Active Pharmaceutical Ingredients | 08/09/2026 | By News Bureau

RPG Life Sciences Subsidiary to Acquire Raghava Life Sciences' API Business for Up to INR 135 Crore

RPG Active Pharma’s latest acquisition expands its manufacturing capacity, API portfolio and regulatory capabilities as part of its buy-and-build strategy.

Active Pharmaceutical Ingredients | 03/09/2026 | By Akanki

Zydus Lifesciences Reports 22 Percent Revenue Growth in Q1 FY27, Advances Innovation Pipeline

Zydus Lifesciences began FY27 with strong double-digit growth, driven by robust performance across India and international formulations, alongside continued progress in manufacturing quality and biosimilar innovation.

Active Pharmaceutical Ingredients | 12/08/2026 | By News Bureau

Gland Pharma and Neuland Partner for Sterile API Manufacturing

Gland Pharma and Neuland Laboratories have partnered to expand sterile Active Pharmaceutical Ingredient (API) manufacturing through a new state-of-the-art current Good Manufacturing Practice (GMP) sterile manufacturing suite.

Active Pharmaceutical Ingredients | 06/08/2026 | By News Bureau

Lupin Launches Generic Sugammadex Injection in the US Following FDA Approval

Lupin launches Sugammadex Injection in the United States after receiving US FDA approval for its Abbreviated New Drug Application. The bioequivalent version of Merck's Bridion Injection is indicated for reversing neuromuscular blockade in adult and paediatric patients aged two years and older undergoing surgery.

Active Pharmaceutical Ingredients | 31/07/2026 | By News Bureau

Nona Biosciences Partners with Medical University of Vienna on Antibody Research

Nona Biosciences has partnered with the Medical University of Vienna to advance fully human antibody development for infectious diseases using its H2L2 Harbour Mice platform.

Active Pharmaceutical Ingredients | 23/07/2026 | By News Bureau

CuraTeQ Biologics Secures ANVISA Approval for Hyderabad Biosimilars Manufacturing Facility

CuraTeQ Biologics has received ANVISA GMP approval for its Hyderabad biosimilars manufacturing facility, strengthening its global regulatory credentials and enabling expanded supply of biosimilar products to Brazil and the wider Latin American market.

Active Pharmaceutical Ingredients | 22/07/2026 | By News Bureau |  167

Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili

Biocon has published pivotal clinical data supporting the effectiveness of Yesafili, its Food and Drug Administration (FDA)-approved interchangeable aflibercept biosimilar, demonstrating comparable safety, efficacy, and immunogenicity.

Active Pharmaceutical Ingredients | 09/07/2026 | By News Bureau |  135

Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis

Sofinnova Partners announced that portfolio company Myricx Bio has agreed to be acquired by Novartis, strengthening the company's oncology pipeline and ADC capabilities.

Active Pharmaceutical Ingredients | 06/07/2026 | By Akanki

DNP Establishes Second Overseas R&D Centre in India at IIT Hyderabad

DNP has established its second overseas R&D base at IIT Hyderabad, India, to accelerate the commercialisation of wireless power supply technologies for Active Pharmaceutical Ingredients (APIs) and Electric Vehicles (EVs), targeting growth opportunities in the Indian and African markets.

Active Pharmaceutical Ingredients | 23/03/2026 | By News Bureau |  144